Voyager Therapeutics Inc (VYGR)
6.22
-0.47
(-7.03%)
USD |
NASDAQ |
Nov 14, 16:00
6.22
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Free Cash Flow: -22.27M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -22.27M |
| March 31, 2024 | 8.233M |
| December 31, 2023 | 74.66M |
| September 30, 2023 | 86.00M |
| June 30, 2023 | 91.35M |
| March 31, 2023 | 73.67M |
| December 31, 2022 | -15.00M |
| September 30, 2022 | 9.025M |
| June 30, 2022 | 4.14M |
| March 31, 2022 | 0.923M |
| December 31, 2021 | -55.13M |
| September 30, 2021 | -91.52M |
| June 30, 2021 | -100.04M |
| March 31, 2021 | -100.18M |
| December 31, 2020 | -108.81M |
| September 30, 2020 | -110.02M |
| June 30, 2020 | -102.88M |
| March 31, 2020 | -113.42M |
| Date | Value |
|---|---|
| December 31, 2019 | 40.95M |
| September 30, 2019 | 42.81M |
| June 30, 2019 | 47.07M |
| March 31, 2019 | 56.86M |
| December 31, 2018 | -20.19M |
| September 30, 2018 | -10.32M |
| June 30, 2018 | -8.119M |
| March 31, 2018 | -1.093M |
| December 31, 2017 | -65.34M |
| September 30, 2017 | -67.30M |
| June 30, 2017 | -61.69M |
| March 31, 2017 | -54.80M |
| December 31, 2016 | -47.51M |
| September 30, 2016 | -40.23M |
| June 30, 2016 | -36.54M |
| March 31, 2016 | -34.12M |
| December 31, 2015 | 40.27M |
Free Cash Flow Range, Past 5 Years
-113.42M
Minimum
Mar 2020
91.35M
Maximum
Jun 2023
-22.65M
Average
-15.00M
Median
Dec 2022
Free Cash Flow Benchmarks
| Rhythm Pharmaceuticals Inc | -124.42M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.58M |
| Cash from Investing (Quarterly) | -35.94M |
| Cash from Financing (Quarterly) | 0.571M |
| Free Cash Flow Per Share (Quarterly) | -0.5639 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.55M |
| Free Cash Flow Yield | -6.85% |